Arcus Biosciences, Inc. (RCUS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 60M 120M 180M Q3 '24: 48M Q4 '24: 26M Q1 '25: 28M Q2 '25: 160M Q3 '25: 26M Q4 '25: 33M Q1 '26: 17M Q2 '26: 41M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '24: -105M Q4 '24: -103M Q1 '25: -122M Q2 '25: -8M Q3 '25: -142M Q4 '25: -114M Q1 '26: -134M Q2 '26: -96M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '24: -92M Q4 '24: -94M Q1 '25: -112M Q2 '25: 0 Q3 '25: -135M Q4 '25: -106M Q1 '26: -128M Q2 '26: -91M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '24: 26M Q4 '24: -100M Q1 '25: -132M Q2 '25: -133M Q3 '25: -97M Q4 '25: -120M Q1 '26: -138M Q2 '26: -119M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '24: 25M Q4 '24: -101M Q1 '25: -133M Q2 '25: -133M Q3 '25: -97M Q4 '25: -121M Q1 '26: -138M Q2 '26: -119M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q1 '24: 86.2M Q2 '24: 91.1M Q3 '24: 91.4M Q1 '25: 98.4M Q2 '25: 106.5M Q3 '25: 106.5M Q1 '26: 125.4M Q2 '26: 126.1M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '24: -3.15 Q4 '24: -3.10 Q1 '25: -4.19 Q2 '25: -3.17 Q3 '25: -3.44 Q4 '25: -3.31 Q1 '26: -3.19 Q2 '26: -3.91 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.